Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Announces Expansion of Credit Facility to include new $700 million term loan
Financing now secured for the planned acquisition of Codman Neurosurgery
View HTML
Toggle Summary Integra LifeSciences Announces Expansion of Credit Facility to $1.1 Billion
PLAINSBORO, N.J., Sept. 1, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it has increased its credit facility with its bank group led by Bank of America, N.A. "We are pleased to improve our overall capital structure by expanding the size of
View HTML
Toggle Summary Integra LifeSciences Announces Expansion and Extension of Credit Facility to $1.5 Billion
PLAINSBORO, N.J., Dec. 07, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it has increased its credit facility with its bank group led by Bank of America, N.A. The expanded and extended credit facility includes the following terms: An increase
View HTML
Toggle Summary Integra LifeSciences Announces Exchange Offer for Its 2 1/2 Percent Contingent Convertible Subordinated Notes Due 2008
Integra LifeSciences Announces Exchange Offer for Its 2 1/2 Percent Contingent Convertible Subordinated Notes Due 2008 PLAINSBORO, N.J., Jul 17, 2006 (PRIMEZONE via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has commenced an offer to
View HTML
Toggle Summary Integra LifeSciences Announces Direct Sales Strategy in Canada
Integra LifeSciences Announces Direct Sales Strategy in Canada Acquires Canada Microsurgical Ltd. PLAINSBORO, N.J., July 11, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is launching a direct sales force in Canada through the acquisition of its
View HTML
Toggle Summary Integra LifeSciences Announces Determination of Entitlement to Contingent Interest On Convertible Notes Due 2008
PLAINSBORO, N.J., Feb 20, 2008 (PrimeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has determined that holders of its 2 1/2% Contingent Convertible Subordinated Notes due 2008 ("Notes") shall be entitled to receive contingent
View HTML
Toggle Summary Integra LifeSciences Announces Definitive Agreement to Sell Certain Neurosurgery Assets to Natus Medical Incorporated
Natus Medical to acquire global Camino® ICP monitoring product line, U.S. rights to Integra's fixed pressure shunts, and U.S. rights to Codman's DURAFORM®, EVD catheters and CSF collection systems Integra is providing a preliminary estimate for a fourth quarter 2017 revenue contribution of
View HTML
Toggle Summary Integra LifeSciences Announces Definitive Agreement to Divest its Extremity Orthopedics Business to Smith+Nephew for $240 Million
PRINCETON, N.J., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has entered into a definitive agreement to sell its Extremity Orthopedics business to Smith+Nephew (LSE:SN, NYSE:SNN) for $240
View HTML
Toggle Summary Integra LifeSciences Announces Definitive Agreement to Acquire Surgical Innovation Associates (SIA) and Plans for $150 Million Share Repurchase
Acquisition will add distinct new product solution for plastic and reconstructive surgery to address clinical needs and improve patient outcomes Deploys capital to support strong profitable growth and greater returns for our shareholders PRINCETON, N.J., Dec.
View HTML
Toggle Summary Integra LifeSciences Announces Definitive Agreement to Acquire ACell, Inc.
Adds proprietary technology platform and complementary products to grow Integra’s regenerative portfolio PRINCETON, N.J., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) a leading global medical technology company, today announced it has entered into a
View HTML